女性复发性尿路感染的非抗生素疗法
Nonantibiotic Therapy for Recurrent Urinary Tract Infection in Women
DOI: 10.12677/acm.2025.15113199, PDF,   
作者: 李 田:成都中医药大学医学与生命科学学院,四川 成都;杨 宇*:宜宾市第一人民医院泌尿外科,四川 宜宾
关键词: 复发性尿路感染非抗生素疗法行为干预膳食补充剂Recurrent Urinary Tract Infection Nonantibiotic Therapy Behavioral Therapy Dietary Supplement
摘要: 复发性尿路感染是女性常见的泌尿系统疾病,反复发作不仅严重影响生活质量,还加剧抗生素药物的使用及耐药问题。近年来,多种非抗生素措施在复发性尿路感染的治疗中展现出潜力。包括局部激素治疗、免疫干预、生活方式调整、膳食补充剂等非抗生素疗法,其在复发性尿路感染中的临床效果突出,显著减少复发率、延缓复发时间、减少抗生素耐药性等,但目前尚不能完全取代传统治疗。未来还需要大样本、多中心的随机对照试验验证其疗效,并探索联合及个体化干预策略,为临床治疗复发性尿路感染提供诊疗新思路。
Abstract: Recurrent urinary tract infection (rUTI) is a common urological condition in women. Its frequent relapses not only impair quality of life but also lead to increased antibiotic use and the emergence of resistance. In recent years, various non-antibiotic strategies have shown promise in the management of rUTI. These include topical hormone therapy, immunomodulation, lifestyle modifications, and dietary supplements, which have demonstrated clinical benefits by reducing recurrence rates, prolonging recurrence intervals, and mitigating antibiotic resistance. However, such interventions cannot yet fully replace conventional antibiotic therapy. Future large-scale, multicenter randomized controlled trials are warranted to further validate their efficacy and safety, as well as to explore combined and individualized approaches, thereby providing new insights into the clinical management of rUTI.
文章引用:李田, 杨宇. 女性复发性尿路感染的非抗生素疗法[J]. 临床医学进展, 2025, 15(11): 1124-1129. https://doi.org/10.12677/acm.2025.15113199

参考文献

[1] Foxman, B. (2014) Urinary Tract Infection Syndromes: Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden. Infectious Disease Clinics of North America, 28, 1-13. [Google Scholar] [CrossRef] [PubMed]
[2] Hooton, T.M., Vecchio, M., Iroz, A., Tack, I., Dornic, Q., Seksek, I., et al. (2018) Effect of Increased Daily Water Intake in Premenopausal Women with Recurrent Urinary Tract Infections: A Randomized Clinical Trial. JAMA Internal Medicine, 178, 1509-1515. [Google Scholar] [CrossRef] [PubMed]
[3] Foxman, B., Gillespie, B., Koopman, J., Zhang, L., Palin, K., Tallman, P., et al. (2000) Risk Factors for Second Urinary Tract Infection among College Women. American Journal of Epidemiology, 151, 1194-1205. [Google Scholar] [CrossRef] [PubMed]
[4] Gustafsson, R.J., Ahrné, S., Jeppsson, B., Benoni, C., Olsson, C., Stjernquist, M., et al. (2011) The Lactobacillus Flora in Vagina and Rectum of Fertile and Postmenopausal Healthy Swedish Women. BMC Womens Health, 11, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, R., Daroczy, K., Xiao, B., Yu, L., Chen, R. and Liao, Q. (2012) Qualitative and Semiquantitative Analysis of Lactobacillus Species in the Vaginas of Healthy Fertile and Postmenopausal Chinese Women. Journal of Medical Microbiology, 61, 729-739. [Google Scholar] [CrossRef] [PubMed]
[6] Perrotta, C., Aznar, M., Mejia, R., Albert, X. and Ng, C.W. (2008) Oestrogens for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women. Cochrane Database of Systematic Reviews, 2, CD005131. [Google Scholar] [CrossRef] [PubMed]
[7] Raz, R. and Stamm, W.E. (1993) A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections. New England Journal of Medicine, 329, 753-756. [Google Scholar] [CrossRef] [PubMed]
[8] Rahn, D.D., Carberry, C., Sanses, T.V., Mamik, M.M., Ward, R.M., Meriwether, K.V., et al. (2014) Vaginal Estrogen for Genitourinary Syndrome of Menopause. Obstetrics & Gynecology, 124, 1147-1156. [Google Scholar] [CrossRef] [PubMed]
[9] Anger, J., Lee, U., Ackerman, A.L., Chou, R., Chughtai, B., Clemens, J.Q., et al. (2019) Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. Journal of Urology, 202, 282-289. [Google Scholar] [CrossRef] [PubMed]
[10] Anger, J.T., Bixler, B.R., Holmes, R.S., Lee, U.J., Santiago-Lastra, Y. and Selph, S.S. (2022) Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. Journal of Urology, 208, 536-541. [Google Scholar] [CrossRef] [PubMed]
[11] Edwards, V.L., Smith, S.B., McComb, E.J., Tamarelle, J., Ma, B., Humphrys, M.S., et al. (2019) The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia Trachomatis Infection. mBio, 10, e01548-19. [Google Scholar] [CrossRef] [PubMed]
[12] Ferrante, K.L., Wasenda, E.J., Jung, C.E., Adams-Piper, E.R. and Lukacz, E.S. (2021) Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. Female Pelvic Medicine & Reconstructive Surgery, 27, 112-117. [Google Scholar] [CrossRef] [PubMed]
[13] Mak, Q., Greig, J., Dasgupta, P., Malde, S. and Raison, N. (2024) Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-Analysis. European Urology Focus, 10, 761-769. [Google Scholar] [CrossRef] [PubMed]
[14] Lorenzo-Gómez, M.F., Padilla-Fernández, B., García-Cenador, M.B., Virseda-Rodríguez, Ã.J., Martín-García, I., Sánchez-Escudero, A., et al. (2015) Comparison of Sublingual Therapeutic Vaccine with Antibiotics for the Prophylaxis of Recurrent Urinary Tract Infections. Frontiers in Cellular and Infection Microbiology, 5, Article 50. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, B. and Foley, S. (2018) First Experience in the UK of Treating Women with Recurrent Urinary Tract Infections with the Bacterial Vaccine Uromune. BJU International, 121, 289-292. [Google Scholar] [CrossRef] [PubMed]
[16] Saz-Leal, P., Ligon, M.M., Diez-Rivero, C.M., García-Ayuso, D., et al, (2023) MV140 Mucosal Bacterial Vaccine Improves Uropathogenic E. coli Clearance in an Experimental Model of Urinary Tract Infection.
[17] Lorenzo-Gómez, M.F., Foley, S., Nickel, J.C., et al. (2022) Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections. NEJM Evidence, 1, EVIDx2200081.
[18] Lorenzo-Gómez, M.F., Padilla-Fernández, B., Flores-Fraile, J., Valverde-Martínez, S., González-Casado, I., Hernández, J.D.D., et al. (2021) Impact of Whole-Cell Bacterial Immunoprophylaxis in the Management of Recurrent Urinary Tract Infections in the Frail Elderly. Vaccine, 39, 6308-6314. [Google Scholar] [CrossRef] [PubMed]
[19] Brodie, A., El-Taji, O., Jour, I., Foley, C. and Hanbury, D. (2020) A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections. Current Urology, 14, 130-134. [Google Scholar] [CrossRef] [PubMed]
[20] Kranz, J., Bartoletti, R., Bruyère, F., Cai, T., Geerlings, S., Köves, B., et al. (2024) European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. European Urology, 86, 27-41. [Google Scholar] [CrossRef] [PubMed]
[21] Naber, K.G., Cho, Y., Matsumoto, T. and Schaeffer, A.J. (2009) Immunoactive Prophylaxis of Recurrent Urinary Tract Infections: A Meta-Analysis. International Journal of Antimicrobial Agents, 33, 111-119. [Google Scholar] [CrossRef] [PubMed]
[22] Prattley, S., Geraghty, R., Moore, M. and Somani, B.K. (2020) Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review. European Urology Focus, 6, 593-604. [Google Scholar] [CrossRef] [PubMed]
[23] González de Llano, D., Moreno-Arribas, M.V. and Bartolomé, B. (2020) Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations. Molecules, 25, Article 3523. [Google Scholar] [CrossRef] [PubMed]
[24] Jagannathan, V. and Viswanathan, P. (2018) Proanthocyanidins—Will They Effectively Restrain Conspicuous Bacterial Strains Devolving on Urinary Tract Infection? Journal of Basic Microbiology, 58, 567-578. [Google Scholar] [CrossRef] [PubMed]
[25] González de Llano, D., Liu, H., Khoo, C., Moreno-Arribas, M.V. and Bartolomé, B. (2019) Some New Findings Regarding the Antiadhesive Activity of Cranberry Phenolic Compounds and Their Microbial-Derived Metabolites against Uropathogenic Bacteria. Journal of Agricultural and Food Chemistry, 67, 2166-2174. [Google Scholar] [CrossRef] [PubMed]
[26] Hidalgo, G., Chan, M. and Tufenkji, N. (2011) Inhibition of Escherichia coli CFT073 Flic Expression and Motility by Cranberry Materials. Applied and Environmental Microbiology, 77, 6852-6857. [Google Scholar] [CrossRef] [PubMed]
[27] Maki, K.C., Kaspar, K.L., Khoo, C., Derrig, L.H., Schild, A.L. and Gupta, K. (2016) Consumption of a Cranberry Juice Beverage Lowered the Number of Clinical Urinary Tract Infection Episodes in Women with a Recent History of Urinary Tract Infection. The American Journal of Clinical Nutrition, 103, 1434-1442. [Google Scholar] [CrossRef] [PubMed]
[28] Kranjčec, B., Papeš, D. and Altarac, S. (2014) D-Mannose Powder for Prophylaxis of Recurrent Urinary Tract Infections in Women: A Randomized Clinical Trial. World Journal of Urology, 32, 79-84. [Google Scholar] [CrossRef] [PubMed]
[29] Schaeffer, A.J., Chmiel, J.S., Duncan, J.L. and Falkowski, W.S. (1984) Mannose-Sensitive Adherence of Escherichia coli to Epithelial Cells from Women with Recurrent Urinary Tract Infections. Journal of Urology, 131, 906-910. [Google Scholar] [CrossRef] [PubMed]
[30] Hayward, G., Mort, S., Hay, A.D., Moore, M., Thomas, N.P.B., Cook, J., et al. (2024) D-Mannose for Prevention of Recurrent Urinary Tract Infection among Women. JAMA Internal Medicine, 184, 619-628. [Google Scholar] [CrossRef] [PubMed]
[31] de Llano, D.G., Arroyo, A., Cárdenas, N., Rodríguez, J.M., Moreno-Arribas, M.V. and Bartolomé, B. (2017) Strain-specific Inhibition of the Adherence of Uropathogenic Bacteria to Bladder Cells by Probiotic Lactobacillus spp. Pathogens and Disease, 75, ftx043. [Google Scholar] [CrossRef] [PubMed]
[32] Schwenger, E.M., Tejani, A.M. and Loewen, P.S. (2015) Probiotics for Preventing Urinary Tract Infections in Adults and Children. Cochrane Database of Systematic Reviews, 2015, CD008772. [Google Scholar] [CrossRef] [PubMed]